查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024075

神經復健機器人市場預測至2034年：按組件、類型、應用、最終用戶和地區分類的全球分析

Neurorehabilitation Robotics Market Forecasts to 2034- Global Analysis By Component (Hardware and Software), Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球神經復健機器人市場規模將達到 12 億美元，並在預測期內以 19.3% 的複合年成長率成長，到 2034 年將達到 49.5 億美元。

神經復健機器人是指用於輔助神經病變患者復健的先進機器人系統和智慧技術。這些系統旨在幫助、增強或恢復受中風、脊髓損傷和帕金森氏症等疾病影響的運動和認知功能。其應用包括機器人外骨骼、末端執行器和治療機器人，能夠進行重複性、精準性和適應性訓練。透過整合感測器、人工智慧和即時回饋，神經復健機器人可以改善患者預後，提高治療效率，並支援在臨床和家庭環境中進行個人化復健。

神經系統疾病發生率增加

中風、脊髓損傷和帕金森氏症等神經系統疾病的日益普遍是推動神經復健機器人市場發展的主要因素。這些疾病通常會導致長期運動功能障礙，需要進行強化復健治療。隨著全球患者數量的成長，醫療系統正在部署機器人解決方案，以提供持續、高品質的照護。神經復健機器人透過重複且精準的動作來增強復健效果，已成為現代復健實踐中不可或缺的工具，並顯著提升了市場需求。

機器人系統高成本

用於神經復健的機器人系統高成本，仍然是其廣泛應用的主要障礙。這些先進設備涉及採購、安裝、維護和培訓等諸多環節，成本不菲。小規模的醫療機構和診所，尤其是在發展中地區，往往難以承擔此類投資。此外，有限的保險報銷機制也進一步限制了病患的就醫途徑。儘管這些系統具有顯著的臨床益處，但其帶來的經濟負擔卻阻礙了市場滲透，並造成了不同地區在取得先進復健技術方面的不平衡。

機器人和人工智慧領域的技術進步

機器人技術、人工智慧和感測器技術的快速發展為市場創造了強勁的成長機會。即時回饋系統、自適應學習演算法和改進的人機介面等創新技術正在提升復健治療的有效性。這些技術能夠實現個人化治療方案，進而提高患者參與度和治療效果。此外，緊湊、易用且經濟高效的機器人系統的開發，正將其應用範圍從醫院擴展到居家照護，顯著提升了全球市場的潛力。

監管和核准的挑戰

監管和核准的挑戰對神經復健機器人市場構成重大威脅。這些設備必須符合各地不同的嚴格醫療設備法規、安全標準和臨床檢驗要求。核准流程可能耗時耗力，阻礙產品商業化和創新。此外，缺乏機器人復健系統的標準化指南也使市場准入更加複雜。這些監管障礙增加了製造商的商業風險，並可能限制先進解決方案及時推向市場。

新冠疫情的影響：

新冠疫情對市場產生了複雜的影響。雖然疫情初期對製造業、供應鏈和部分復健服務造成了衝擊，但危機也加速了自動化和遠距復健解決方案的普及。減少人際接觸的需求提升了人們對機器人輔助治療和遠距復健的興趣。醫療機構開始採用先進技術以確保醫療服務的連續性。因此，疫情凸顯了機器人技術在復健領域的價值，儘管短期內遭遇了一些挫折，但最終還是推動了市場的長期成長。

在預測期內，下肢機器人細分市場預計將成為規模最大的細分市場。

由於神經系統疾病導致的運動障礙盛行率高，預計下肢機器人領域在預測期內將佔據最大的市場佔有率。這些機器人廣泛應用於步態訓練和運動功能恢復，尤其適用於中風和脊髓損傷患者的復健。它們能夠提供重複且可控的運動，從而改善復健效果。對高效移動解決方案日益成長的需求，以及外骨骼技術的進步，正在推動下肢機器人系統的應用。

在預測期內，中風復健領域預計將呈現最高的複合年成長率。

在預測期內，由於全球中風發病率不斷上升以及對中風後強化治療的需求日益成長，中風復健領域預計將呈現最高的成長率。中風患者通常需要長期復健才能恢復運動功能，因此機器人輔助解決方案的需求十分旺盛。這些系統能夠達到精準、重複的動作，進而改善復健效果。人們對早期復健的認知不斷提高以及技術的進步，正進一步加速機器人技術在中風治療計畫中的應用。

市佔率最大的地區：

在預測期內，亞太地區預計將佔據最大的市場佔有率，這主要得益於其龐大的患者群體和快速老化的人口結構。神經系統疾病盛行率的不斷上升，以及醫療基礎設施的不斷完善，正在推動對先進復健解決方案的需求。各國政府正加大對醫療現代化的投入，並積極推廣創新技術的應用。此外，新興經濟體的崛起以及人們對復健療法日益成長的認知，也顯著鞏固了該地區的市場主導地位。

複合年成長率最高的地區：

在預測期內，北美預計將呈現最高的複合年成長率，這主要得益於顯著的技術進步和高昂的醫療支出。該地區受益於創新機器人系統的早期應用以及主要市場參與者的存在。人們日益關注改善復健效果和降低長期醫療保健成本，這正在推動市場需求。此外，有利的法規結構、持續的研究活動以及對先進復健技術的日益了解，也促進了該地區市場的快速成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章 全球神經復健機器人市場：依組件分類

  • 硬體
  • 軟體

第6章：全球神經復健機器人市場：按類型分類

  • 上肢機器人
  • 下肢機器人
  • 外骨骼機器人
  • 末端執行器機器人
  • 跑步機式機器人

第7章 全球神經復健機器人市場：依應用領域分類

  • 中風復健
  • 脊髓損傷康復
  • 創傷性腦損傷康復
  • 腦性麻痹復健
  • 帕金森氏症康復

第8章 全球神經復健機器人市場：依最終用戶分類

  • 醫院和診所
  • 復健中心
  • 居家照護環境

第9章：全球神經復健機器人市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • Ekso Bionics Holdings, Inc.
  • Cyberdyne Inc.
  • Bionik Laboratories Corp.
  • Hocoma AG（DIH Medical Group）
  • ReWalk Robotics Ltd.
  • Lifeward, Inc.
  • Tyromotion GmbH
  • Fourier Intelligence
  • Myomo, Inc.
  • Kinova Inc.
  • Rehab-Robotics Company Limited
  • AlterG, Inc.
  • Wandercraft SAS
  • MediTouch Ltd.
  • Rex Bionics Ltd.
Product Code: SMRC35287

According to Stratistics MRC, the Global Neurorehabilitation Robotics Market is accounted for $1.20 billion in 2026 and is expected to reach $4.95 billion by 2034 growing at a CAGR of 19.3% during the forecast period. Neurorehabilitation robotics refers to the application of advanced robotic systems and intelligent technologies to support the recovery of individuals with neurological impairments. These systems are designed to assist, enhance, or restore motor and cognitive functions affected by conditions such as stroke, spinal cord injury, and Parkinson's disease. They include robotic exoskeletons, end effector devices, and therapy robots that enable repetitive, precise, and adaptive training. By integrating sensors, artificial intelligence, and real-time feedback, neurorehabilitation robotics improves patient outcomes, enhances therapy efficiency, and supports personalized rehabilitation across clinical and home-based settings.

Market Dynamics:

Driver:

Rising incidence of neurological disorders

The increasing prevalence of neurological disorders such as stroke, spinal cord injury, and Parkinson's disease is a major driver for the neurorehabilitation robotics market. These conditions often result in long-term motor impairments requiring intensive rehabilitation. As patient volumes rise globally, healthcare systems are adopting robotic solutions to deliver consistent, high-quality therapy. Neurorehabilitation robots enhance recovery outcomes through repetitive, precise movements, making them essential tools in modern rehabilitation practices and significantly boosting market demand.

Restraint:

High cost of robotic systems

The high cost of neurorehabilitation robotic systems remains a significant barrier to widespread adoption. These advanced devices involve substantial expenses related to procurement, installation, maintenance, and training. Smaller healthcare facilities and clinics, particularly in developing regions, often struggle to justify such investments. Additionally, limited reimbursement policies further restrict accessibility for patients. Despite their clinical benefits, the financial burden associated with these systems slows market penetration and creates disparities in access to advanced rehabilitation technologies across different regions.

Opportunity:

Technological advancements in robotics & AI

Rapid advancements in robotics, artificial intelligence, and sensor technologies present strong growth opportunities for the market. Innovations such as real-time feedback systems, adaptive learning algorithms, and improved human-machine interfaces are enhancing the effectiveness of rehabilitation therapies. These technologies enable personalized treatment plans and improve patient engagement and outcomes. Furthermore, the development of compact, user-friendly, and cost-effective robotic systems is expanding their application beyond hospitals into home-based care, significantly broadening the market's potential globally.

Threat:

Regulatory and approval challenges

Regulatory and approval challenges pose a significant threat to the neurorehabilitation robotics market. These devices must comply with stringent medical device regulations, safety standards, and clinical validation requirements, which vary across regions. The approval process can be lengthy and costly, delaying product commercialization and innovation. Additionally, the lack of standardized guidelines for robotic rehabilitation systems complicates market entry. These regulatory hurdles increase operational risks for manufacturers and may limit the timely availability of advanced solutions in the market.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the market. While initial disruptions affected manufacturing, supply chains, and elective rehabilitation services, the crisis accelerated the adoption of automated and remote rehabilitation solutions. The need to minimize physical contact increased interest in robotic-assisted therapy and tele-rehabilitation. Healthcare providers began integrating advanced technologies to ensure continuity of care. As a result, the pandemic highlighted the value of robotics in rehabilitation, ultimately supporting long-term market growth despite short-term setbacks.

The lower limb robots segment is expected to be the largest during the forecast period

The lower limb robots segment is expected to account for the largest market share during the forecast period, due to high prevalence of mobility impairments caused by neurological conditions. These robots are widely used in gait training and mobility restoration, particularly for patients recovering from stroke or spinal cord injuries. Their ability to provide repetitive, controlled movement enhances rehabilitation outcomes. Increasing demand for effective mobility solutions, along with advancements in exoskeleton technologies, is driving the widespread adoption of lower limb robotic systems.

The stroke rehabilitation segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the stroke rehabilitation segment is predicted to witness the highest growth rate, due to the rising global incidence of stroke and the need for intensive post-stroke therapy. Stroke patients often require long-term rehabilitation to regain motor functions, creating strong demand for robotic-assisted solutions. These systems enable precise, repetitive movements that improve recovery outcomes. Growing awareness about early rehabilitation and technological advancements are further accelerating the adoption of robotics in stroke treatment programs.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its large patient population and rapidly aging demographics. Increasing prevalence of neurological disorders, coupled with improving healthcare infrastructure, is driving demand for advanced rehabilitation solutions. Governments are investing in healthcare modernization and promoting the adoption of innovative technologies. Additionally, the presence of emerging economies and growing awareness about rehabilitation therapies contribute significantly to the region's dominant position in the market.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong technological advancements and high healthcare spending. The region benefits from early adoption of innovative robotic systems and the presence of leading market players. Increasing focus on improving rehabilitation outcomes and reducing long-term healthcare costs is driving demand. Additionally, supportive regulatory frameworks, ongoing research activities, and growing awareness about advanced rehabilitation technologies are contributing to the region's rapid market growth.

Key players in the market

Some of the key players in Neurorehabilitation Robotics Market include Ekso Bionics Holdings, Inc., Cyberdyne Inc., Bionik Laboratories Corp., Hocoma AG (DIH Medical Group), ReWalk Robotics Ltd., Lifeward, Inc., Tyromotion GmbH, Fourier Intelligence, Myomo, Inc., Kinova Inc., Rehab-Robotics Company Limited, AlterG, Inc., Wandercraft SAS, MediTouch Ltd. and Rex Bionics Ltd.

Key Developments:

In January 2026, Lifeward entered a strategic partnership with Oramed to transform into a diversified biomedical innovation company, integrating Oramed's oral drug delivery technology while gaining access to up to $47 million in funding to support profitability and long-term growth.

In December 2025, Ekso Bionics entered an agreement with MediTouch to become the exclusive U.S. distributor of its BalanceTutor rehabilitation system, expanding its product portfolio and strengthening its position in neurorehabilitation by offering advanced balance training solutions to healthcare providers.

Components Covered:

  • Hardware
  • Software

Types Covered:

  • Upper Limb Robots
  • Lower Limb Robots
  • Exoskeleton Robots
  • End-Effector Robots
  • Treadmill-Based Robots

Applications Covered:

  • Stroke Rehabilitation
  • Spinal Cord Injury Rehabilitation
  • Traumatic Brain Injury Rehabilitation
  • Cerebral Palsy Rehabilitation
  • Parkinson's Disease Rehabilitation

End Users Covered:

  • Hospitals & Clinics
  • Rehabilitation Centers
  • Homecare Settings

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Neurorehabilitation Robotics Market, By Component

  • 5.1 Hardware
  • 5.2 Software

6 Global Neurorehabilitation Robotics Market, By Type

  • 6.1 Upper Limb Robots
  • 6.2 Lower Limb Robots
  • 6.3 Exoskeleton Robots
  • 6.4 End-Effector Robots
  • 6.5 Treadmill-Based Robots

7 Global Neurorehabilitation Robotics Market, By Application

  • 7.1 Stroke Rehabilitation
  • 7.2 Spinal Cord Injury Rehabilitation
  • 7.3 Traumatic Brain Injury Rehabilitation
  • 7.4 Cerebral Palsy Rehabilitation
  • 7.5 Parkinson's Disease Rehabilitation

8 Global Neurorehabilitation Robotics Market, By End User

  • 8.1 Hospitals & Clinics
  • 8.2 Rehabilitation Centers
  • 8.3 Homecare Settings

9 Global Neurorehabilitation Robotics Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Ekso Bionics Holdings, Inc.
  • 12.2 Cyberdyne Inc.
  • 12.3 Bionik Laboratories Corp.
  • 12.4 Hocoma AG (DIH Medical Group)
  • 12.5 ReWalk Robotics Ltd.
  • 12.6 Lifeward, Inc.
  • 12.7 Tyromotion GmbH
  • 12.8 Fourier Intelligence
  • 12.9 Myomo, Inc.
  • 12.10 Kinova Inc.
  • 12.11 Rehab-Robotics Company Limited
  • 12.12 AlterG, Inc.
  • 12.13 Wandercraft SAS
  • 12.14 MediTouch Ltd.
  • 12.15 Rex Bionics Ltd.

List of Tables

  • Table 1 Global Neurorehabilitation Robotics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Neurorehabilitation Robotics Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global Neurorehabilitation Robotics Market Outlook, By Hardware (2023-2034) ($MN)
  • Table 4 Global Neurorehabilitation Robotics Market Outlook, By Software (2023-2034) ($MN)
  • Table 5 Global Neurorehabilitation Robotics Market Outlook, By Type (2023-2034) ($MN)
  • Table 6 Global Neurorehabilitation Robotics Market Outlook, By Upper Limb Robots (2023-2034) ($MN)
  • Table 7 Global Neurorehabilitation Robotics Market Outlook, By Lower Limb Robots (2023-2034) ($MN)
  • Table 8 Global Neurorehabilitation Robotics Market Outlook, By Exoskeleton Robots (2023-2034) ($MN)
  • Table 9 Global Neurorehabilitation Robotics Market Outlook, By End-Effector Robots (2023-2034) ($MN)
  • Table 10 Global Neurorehabilitation Robotics Market Outlook, By Treadmill-Based Robots (2023-2034) ($MN)
  • Table 11 Global Neurorehabilitation Robotics Market Outlook, By Application (2023-2034) ($MN)
  • Table 12 Global Neurorehabilitation Robotics Market Outlook, By Stroke Rehabilitation (2023-2034) ($MN)
  • Table 13 Global Neurorehabilitation Robotics Market Outlook, By Spinal Cord Injury Rehabilitation (2023-2034) ($MN)
  • Table 14 Global Neurorehabilitation Robotics Market Outlook, By Traumatic Brain Injury Rehabilitation (2023-2034) ($MN)
  • Table 15 Global Neurorehabilitation Robotics Market Outlook, By Cerebral Palsy Rehabilitation (2023-2034) ($MN)
  • Table 16 Global Neurorehabilitation Robotics Market Outlook, By Parkinson's Disease Rehabilitation (2023-2034) ($MN)
  • Table 17 Global Neurorehabilitation Robotics Market Outlook, By End User (2023-2034) ($MN)
  • Table 18 Global Neurorehabilitation Robotics Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 19 Global Neurorehabilitation Robotics Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
  • Table 20 Global Neurorehabilitation Robotics Market Outlook, By Homecare Settings (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.